]>
IRCT20200107046047N1 IRCT 2020-04-07 Kashan University of Medical Sciences Probiotic in treatment of pneumonia The effect of probiotic on improvement of pneumonia 2018-01-30 anticipated 100 Complete https://irct.ir/trial/44885 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: We divide each referral into two groups using a randomized table. This table is a collection of number. Consider numbers from 1 to 50 for intervention and numbers 51 to 100 for control . The lets move on one of the numbers and move in one of the preset directions and assign the numbers to one of the groups.Thus patients are completely randomly divided, Blinding description: Participants, principal investigator, clinical caregivers. 3 Bacterial pneumonia. Intervention 1: Intervention group: Two sachets of probiotic daily for 5 days, product of Biology fermentation company. Intervention 2: Control group: Two sachets of placebo daily for 5 days, product of Farabi company. Yes - There is a plan to make this available What will be shared: Journal file in website of deputy of research and technology of Kashan Medical Sciences When: since 2020 To whom: Universities of Medical Science Conditions: for the purpose of scientific exploitation Where to obtain: Journal file in website of deputy of research and technology of Kashan Medical Sciences How to obtain: Search of journal title in website of deputy of research and technology of Kashan Medical Sciences Comments:
public Dr ŮŽAhmad Najafi
Third floor, Zagros building, Baran street, Shohada fin bozorg bulvard, Amerieh square, Amir Kabir street
Kashan Iran (Islamic Republic of) 8718615699 +98 31 5533 0489 a.najafi1975@yahoo.com Kashan University of Medical Sciences scientific Dr Ahmad Najafi
Third floor, Zagros building, Baran street, Shohada fin bozorg bulvard, Amerieh square, Amir Kabir street
Kashan Iran (Islamic Republic of) 8718615699 +98 31 5533 0489 a.najafi1975@yahoo.com Kashan University of Medical Sciences Iran (Islamic Republic of) Age over 12 years. Bacterial pneumonia is early diagnosis. Taking written consent from the patient to participate in the study. The patient is able to eat probiotic or placebo. Pneumonia is not very severe requiring admission in ICU. 12 years no limit Both The patient has no previous heart failure and pulmonary edema. No underlying pulmonary disease. Intolerance or allergy to probiotic. Dissatisfaction of patients for participating in study. J15 Bacterial pneumonia, not elsewhere classified Treatment - Drugs Placebo Intervention group: Two sachets of probiotic daily for 5 days, product of Biology fermentation company Control group: Two sachets of placebo daily for 5 days, product of Farabi company Duration of hospitalization. Timepoint: From hospitalization to discharge. Method of measurement: Number of days of hospitalization based on patient file and questionnaire. Dyspnea duration. Timepoint: From hospitalization to discharge. Method of measurement: Completion of questionnaire and examination of patient. Tachypnea duration. Timepoint: From hospitalization to discharge. Method of measurement: Completion of questionnaire and examination of patient. Duration of cough. Timepoint: From hospitalization to discharge. Method of measurement: Completion of questionnaire and examination of patient. Duration of lung auscultation rales. Timepoint: From hospitalization to discharge. Method of measurement: Patient examination and questionnaire completion. Duration of fever. Timepoint: From hospitalization to discharge. Method of measurement: Patient examination and questionnaire completion. Kashan University of Medical Sciences Approved 2018-01-29 Ethics committee of Kashan University of Medical Sciences Third floor, Zagros building, Baran street, Shohada fin bozorg bulvard, Amerieh square, Amir Kabir street Kashan Isfehan Iran (Islamic Republic of)